LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3152 | 3673 | 0.8581 | 0.8317 |
SK-BR-3 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1401 | 1574 | 4168 | 0.3776 | 0.0762 |
BT-20 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3253 | 3673 | 0.8856 | 0.8654 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2749 | 4405 | 0.6241 | 0.5463 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 2817 | 4012 | 0.7008 | 0.6263 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3611 | 3761 | 0.9601 | 0.9678 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 1713 | 10692 | 0.1603 | 0.1807 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4078 | 4405 | 0.9259 | 0.9175 |
SK-BR-3 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1401 | 1550 | 4168 | 0.3716 | 0.0641 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3670 | 3761 | 0.9759 | 0.9806 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3761 | 0.9457 | 0.9560 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3665 | 4012 | 0.9147 | 0.9003 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4254 | 4405 | 0.9654 | 0.9608 |
SK-BR-3 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1401 | 1437 | 4168 | 0.3450 | 0.0161 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3666 | 4012 | 0.9160 | 0.9019 |
SK-BR-3 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1401 | 1416 | 4168 | 0.3400 | 0.0066 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2739 | 4405 | 0.6225 | 0.5442 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3577 | 4405 | 0.8130 | 0.7868 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1209 | 922 | 4012 | 0.2304 | -0.1451 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3723 | 4012 | 0.9287 | 0.9168 |
BT-20 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1097 | 816 | 3673 | 0.2224 | -0.1564 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3341 | 3761 | 0.8883 | 0.9080 |
MDA-MB-231 | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4249 | 4660 | 0.9106 | 0.9034 |
BT-20 | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1241 | 3846 | 0.3224 | 0.0683 |
SK-BR-3 | Alpelisib | 10 | uM | LJP5 | 72 | hr | 1401 | 1593 | 4245 | 0.3756 | 0.0817 |